While a headache is a symptom, a migraine is a neurological condition that affects millions worldwide and can cause significant disability in those who suffer from it. It's estimated that up to 15 ...

FDA Approves Symbravo for Acute Treatment of Migraine in Adults By Lori Solomon HealthDay Reporter WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved ...

Read full article: ‘My forever shining star’: Community continues to remember and honor 7-year-old boy killed in shooting K9s For Warriors hosted a free dog adoption event with local animal ...

Zavegepant nasal spray yielded sustained relief of acute pain and function in migraine and may benefit patients for whom triptans are inappropriate. Compared with placebo, zavegepant provides ...

The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.

A Seasonal Return: Warmer temperatures are on the way after a chilly 2025 start (.) For those eagerly anticipating a return to more seasonal temperatures, your patience is about to pay off. After ...

The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at least two oral ...

Listen to Story Air-to-ground missile Rampage hits targets up to 250 kms away Missile surpasses range of Spice-2000 used in 2019 Balakote strikes Successful test of Rampage missile with 150 kg payload ...

Migraine with brainstem aura or MBA (formerly known as basilar migraines) are headaches that start in the lower part of the brain, called the brainstem. They cause symptoms such as dizziness ...

The pharmaceutical giant Pfizer will pay nearly $60 million to resolve charges that a company it acquired paid kickbacks so that physicians would prescribe a specific migraine drug to patients ...